Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSK | P43235 | 15/20 | 0.49 |
| ▸ | CTSS | P25774 | 4/20 | 0.47 |
| ▸ | PPARA | Q07869 | 2/20 | 0.41 |
| ▸ | PPARG | P37231 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | PLA2G2C | Q5R387 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16558033 | 1.00 | CTSK (0.49) | CTSKCTSSPPARAPPARGCYP1A2 | |
| SCHEMBL17393 | 0.87 | PPARA (0.53) | CTSKCTSSPPARAPPARG | |
| SCHEMBL805173 | 0.87 | PPARA (0.53) | CTSKCTSSPPARAPPARG | |
| SCHEMBL13365298 | 0.87 | PPARA (0.53) | CTSKCTSSPPARAPPARG | |
| SCHEMBL16561624 | 0.87 | CTSK (0.45) | CTSKCTSSPPARA | |
| SCHEMBL12244563 | 0.87 | CTSK (0.45) | CTSKCTSSPPARA | |
| SCHEMBL23822627 | 0.86 | CTSK (0.48) | CTSKCTSSPPARAPPARGCYP1A2 | |
| SCHEMBL25527211 | 0.86 | CTSK (0.48) | CTSKCTSSPPARAPPARGCYP1A2 | |
| SCHEMBL15289784 | 0.86 | CTSK (0.48) | CTSKCTSSPPARAPPARGCYP1A2 | |
| SCHEMBL15289799 | 0.86 | CTSK (0.49) | CTSKCTSSPPARAPPARGCYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3041827-B1 | 1,2,4-OXADIAZOLE DERIVATIVES AS IMMUNOMODULATORS | AURIGENE DISCOVERY TECH LTD (IN) | 2018-04-18 | — | — | EP | disclosed |